European regulator rejects study criticising patient organisations' commercial links
This article was originally published in Scrip
Executive Summary
The European Medicines Agency has rejected the conclusions of a survey by the civil society organisation Health Action International (HAI) claiming that the EMA is not doing enough to ensure that its patient and consumer stakeholder organisations are transparent in their disclosure of funds received from industry.